Not known Facts About Sepantronium bromide
123). It can be noteworthy that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This implies that GLS2 could confer resistance to GLS1-distinct inhibitors, including the allosteric inhibitor BPTES or CB-839, and this resistance might be hypothetically prevented by th